Breadcrumb Home Middle life years Betaferon in mid-life or older patients with MS BETAFERON in mid-life or older patients with MS Aspects to consider Mode of action of BETAFERON in MS Read more Clinical data Read more Should treatment be continued when MS patients get older and disease is less active? Read more De-escalation of therapy Read more Treatment of mid-life or older patients with MS – safety considerations Read more Return to 'middle life years'
